Vapotherm
Develops and manufactures innovative, comfortable, noninvasive technologies for respiratory support of patients with chronic or acute breathing disorders. Learn more
Launch date
Employees
Market cap
$13.5m
Enterprise valuation
$133m (Public information from Sep 2024)
Share price
$2.17 VAPO
Exeter United States (HQ)
Authorizing premium user...